Clinical Trial Update: BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a breath test (BreathID 13C-Methacetin Breath Test) aimed at detecting cirrhosis in chronic liver disease; trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Disease

Drugs mentioned

• BreathID 13C-Methacetin Breath Test (13C-methacetin breath test)

Snippet

Sponsor: Meridian Bioscience, Inc. | Conditions: Chronic Liver Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-03-16